Loading…
Ag-doping regulates the cytotoxicity of TiO2 nanoparticles via oxidative stress in human cancer cells
We investigated the anticancer potential of Ag-doped (0.5–5%) anatase TiO 2 NPs. Characterization study showed that dopant Ag was well-distributed on the surface of host TiO 2 NPs. Size (15 nm to 9 nm) and band gap energy (3.32 eV to 3.15 eV) of TiO 2 NPs were decreases with increasing the concentra...
Saved in:
Published in: | Scientific reports 2017-12, Vol.7 (1), p.1-14, Article 17662 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We investigated the anticancer potential of Ag-doped (0.5–5%) anatase TiO
2
NPs. Characterization study showed that dopant Ag was well-distributed on the surface of host TiO
2
NPs. Size (15 nm to 9 nm) and band gap energy (3.32 eV to 3.15 eV) of TiO
2
NPs were decreases with increasing the concentration of Ag dopant. Biological studies demonstrated that Ag-doped TiO
2
NP-induced cytotoxicity and apoptosis in human liver cancer (HepG2) cells. The toxic intensity of TiO
2
NPs was increases with increasing the amount of Ag-doping. The Ag-doped TiO
2
NPs further found to provoke reactive oxygen species (ROS) generation and antioxidants depletion. Toxicity induced by Ag-doped TiO
2
NPs in HepG2 cells was efficiently abrogated by antioxidant N-acetyl-cysteine (ROS scavenger). We also found that Ag-doped TiO
2
NPs induced cytotoxicity and oxidative stress in human lung (A549) and breast (MCF-7) cancer cells. Interestingly, Ag-doped TiO
2
NPs did not cause much toxicity to normal cells such as primary rat hepatocytes and human lung fibroblasts. Overall, we found that Ag-doped TiO
2
NPs have potential to selectively kill cancer cells while sparing normal cells. This study warranted further research on anticancer potential of Ag-doped TiO
2
NPs in various types of cancer cells and
in vivo
models. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-17559-9 |